S Y M B I C O R T i s a r e g i s t e r e d t r a d e m a r k o f t h e A s t r a Z e n e c a g r o u p o f c o m p a n i e s .

© 2 0 1 0

A s t r a Z e n e c a L P .

A ll r i g h t s r e s e r v e d .

3 0 3 6 3 3

6 /1 0

SYMBICORT is fo r asthm a th a t is not w ell controlled on a long-term asthm a m edicine, or w hen disease severity w arrants

M y a s t h m a .

. .

u n d e r c o n t r o l w

i t h

t h e

h e l p o f S Y M B I C O R T ,

h t

When my symptoms came back, my doctor and I chose SYMBICORT to help improve my lung function.

SYMBICORT helps m e breathe b e tte r all day, sta rtin g w ith in 15 m inutes.* It w o n ’t replace a rescue inhaler

fo r sudden sym ptom s. U nlike m ost o the r asthm a m edicines, SYMBICORT com bines tw o m edicines to

help control inflam m ation and co n strictio n .

• Your results may vary.

Ask your doctor if SYMBICORT is a good choice for you.

H

IMPORTANT INFORMATION ABOUT SYMBICORT

Im p o rta n t Safety Inform ation A bout SYMBICORT fo r Asthm a

SYMBICORT contains form oterol, a long-acting beta2-adrenergic

agonist (LABA). LABA m edicines such as form oterol increase the risk of

death from asthma problems. It is not know n w hether budesonide, the

other m edicine in SYMBICORT, reduces the risk o f death from asthma

problem s seen w ith form oterol.

SYMBICORT should be used only if your healthcare provider decides

th at your asthma is not w ell controlled w ith a long-term asthma control

m edicine, such as an inhaled corticosteroid, or th at your asthma is severe

enough to begin treatm ent w ith SYMBICORT.

If you are taking SYMBICORT, see your healthcare provider if your asthma does

not improve or gets worse. It is important that your healthcare provider assess

your asthma control on a regular basis. Your doctor will decide if it is possible

for you to stop taking SYMBICORT and start taking a long-term asthma control

medicine without loss of asthma control.

SYMBICORT does not replace rescue inhalers for sudden asthma symptoms.

Be sure to tell your healthcare provider about all your health conditions,

including heart conditions or high blood pressure, and all medicines you may

be taking. Some patients taking SYMBICORT may experience increased blood

pressure, heart rate, or change in heart rhythm.

Do not use SYMBICORT more often than prescribed. While taking SYMBICORT,

never use another medicine containing a LABA for any reason. Ask your

healthcare provider or pharmacist if any of your other medicines are LABA

medicines, as using too much LABA may cause chest pain, increase in blood

pressure, fast and irregular heartbeat, headache, tremor, and nervousness.

Patients taking SYMBICORT

• may experience serious allergic reactions including rash, hives, swelling

of the face, mouth and tongue, and breathing problems.

• may have a higher chance of infection. Tell your healthcare provider

immediately if you think you are exposed to infections such as chicken

pox or measles, or if you have any signs of infection.

• may experience an increase in wheezing right after taking SYMBICORT,

eye problems including glaucoma and cataracts, decreases in bone mineral

density, swelling of blood vessels, decrease in blood potassium and increase

in blood sugar levels.

If you are switching to SYMBICORT from an oral corticosteroid, follow your

healthcare provider’s instructions to avoid serious health risks when you stop

using oral corticosteroids.

Children and adolescents who take LABA medicines may have an increased

risk of being hospitalized for asthma problems.

Common side effects include nose and throat irritation, headache, upper

respiratory tract infection, sore throat, sinusitis, stomach discomfort, flu, back

pain, nasal congestion, vomiting, and thrush in the mouth and throat.

A pproved Uses fo r SYMBICORT fo r Asthm a

SYMBICORT is used to control and prevent symptoms of asthma in adults and

children ages 12 and older. SYMBICORT is not for patients who have sudden

asthma symptoms.

Please see Im portant Product Inform ation on adjacent page and discuss

w ith your doctor.

You a re e n c o u ra g e d to re p o rt n e g a tiv e s id e e ffe c ts o f p re s c rip tio n

d ru g s to th e FDA. V isit w w w .fd o .g o v /m e d w o tc h , o r c o ll 1-8 0 0 -FD A -1 0 8 8 .

F R E E

P R E S C R I P T I O N 0

F F E R +

A n d e ven m o re s a v in g s fo r u p to a year.* C all 1-8 8 8 -3 1 2 -0 7 9 2

o r v is it M y S y m b ic o rt.c o m /s a v e

1

Subject to eligibility rules. Restrictions apply.

F o r m o r e in f o r m a t io n , c a ll 1 - 8 8 8 -3 1 2 - 0 7 9 2

o r g o t o M y S y m b ic o r t . c o m / s a v e

I f y o u ’r e w i t h o u t p r e s c r i p t i o n c o v e r a g e a n d c a n ’t a f f o r d

y o u r m e d i c a t io n , A s t r a Z e n e c a m a y b e a b l e t o h e lp .

F o r m o r e in f o r m a t io n , p l e a s e v is it w w w . a s t r a z e n e c a - u s . c o m

S y m b i c o r t

(budesonide/formoterol fumarate dihydrate)

Inhalation Aerosol

A s t r a Z e n e c a

Z